<SEC-DOCUMENT>0001731122-20-000289.txt : 20200323
<SEC-HEADER>0001731122-20-000289.hdr.sgml : 20200323
<ACCEPTANCE-DATETIME>20200323080037
ACCESSION NUMBER:		0001731122-20-000289
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20200323
DATE AS OF CHANGE:		20200323
EFFECTIVENESS DATE:		20200323

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ANAVEX LIFE SCIENCES CORP.
		CENTRAL INDEX KEY:			0001314052
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				208365999
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37606
		FILM NUMBER:		20733625

	BUSINESS ADDRESS:	
		STREET 1:		51 W 52ND STREET,
		STREET 2:		7TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019-6163
		BUSINESS PHONE:		800-689-3939

	MAIL ADDRESS:	
		STREET 1:		51 W 52ND STREET,
		STREET 2:		7TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019-6163

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Thrifty Printing Inc.
		DATE OF NAME CHANGE:	20050111
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>e1821_defa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 18pt"><B>UNITED STATES
</B></FONT><BR>
<FONT STYLE="font-size: 18pt"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT><BR>
<FONT STYLE="font-size: 18pt"><B>Washington, D.C. 20549</B></FONT></P>

<P STYLE="margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 18pt"><B>SCHEDULE
14A</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Proxy Statement Pursuant to Section
14(a) of the Securities Exchange Act of 1934 </B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(Amendment No. )</B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">Filed by the Registrant&nbsp;&nbsp; [X]<BR>
Filed by a Party other than the Registrant &nbsp;&nbsp;[&nbsp; &nbsp;]</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">Check the appropriate box:</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">[ ] Preliminary Proxy Statement<BR>
[&nbsp; &nbsp;] <B>Confidential, For Use of the Commission Only (As Permitted by Rule 14a-6(e)(2)) </B><BR>
[X] Definitive Proxy Statement<BR>
[&nbsp; &nbsp;] Definitive Additional Materials<BR>
[&nbsp; &nbsp;] Soliciting Material under Rule 14a-12</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 18pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>ANAVEX LIFE SCIENCES CORP. </U></B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center"><I>(Name of Registrant as Specified In
Its Charter) </I></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">___________________________________________<I><BR>
(Name of Person(s) Filing Proxy Statement, if </I><BR>
<I>other than the Registrant)</I></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">Payment of Filing Fee (Check the appropriate box):</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">[X] No fee required</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">[&nbsp; &nbsp;] Fee computed on table below per Exchange Act
Rules 14a-6(i)(1) and 0-11.</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">(1) Title of each class of securities to which transaction
applies:<BR>
(2) Aggregate number of securities to which transaction applies:<BR>
(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on
which the filing fee is calculated and state how it was determined):<BR>
(4) Proposed maximum aggregate value of transaction:<BR>
(5) Total fee paid:</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">[&nbsp;&nbsp; ] Fee paid previously with preliminary materials.</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">[&nbsp; &nbsp;] Check box if any part of the fee is offset
as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify
the previous filing by registration statement number, or the form or schedule and the date of its filing.</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">(1) Amount Previously Paid:<BR>
(2) Form, Schedule or Registration Statement No.:<BR>
(3) Filing Party:<BR>
(4) Date Filed:</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center"><B>ANAVEX LIFE SCIENCES CORP.<BR>
51 W 52<SUP>nd </SUP>Street, 7<SUP>th </SUP>Floor, New York, NY 10019 </B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0"><B>ADDITIONAL INFORMATION REGARDING THE ANNUAL MEETING OF SHAREHOLDERS
TO BE HELD ON APRIL 7, 2020</B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt/115% Times New Roman, Times, Serif; margin: 0">The following Notice of Change of Location relates to the proxy
statement (the &ldquo;Proxy Statement&rdquo;) of Anavex Life Sciences Corp. (the &ldquo;Company&rdquo;), dated February 20, 2020,
furnished to shareholders of the Company in connection with the solicitation of proxies by the Board of Directors of the Company
for use at the 2020 Annual Meeting of Shareholders (the &ldquo;Annual Meeting&rdquo;) to be held on Tuesday April 7, 2020. This
Supplement is being filed with the Securities and Exchange Commission and is being made available to shareholders on or about March&nbsp;23,
2020.</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0"><B>THIS NOTICE SHOULD BE READ IN CONJUNCTION WITH THE PROXY
STATEMENT.</B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>NOTICE OF CHANGE OF LOCATION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OF ANNUAL MEETING OF STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>TO BE HELD ON APRIL 7, 2020</B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">Dear Stockholder:</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Due to the current
emerging public health impact and following the directions of New York City Health Department (www.nyc.gov) precautions related
to the coronavirus (COVID-19) and to support the health and well-being of our shareholders, directors and officers, NOTICE IS HEREBY
GIVEN that the location of the Annual Meeting of Shareholders of Anavex Life Sciences Corp. (the &ldquo;Company&rdquo;) has been
changed. As previously announced, the Annual Meeting will be held on Tuesday, April 7, 2020 at 10:00 a.m., Eastern Time. Following
the directions of New York City Health Department (www.nyc.gov) precautions related to the coronavirus, the Annual Meeting will
be held in a&nbsp;virtual&nbsp;meeting format only. You will not be able to attend the Annual Meeting in person.</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="line-height: 115%">As
described in the proxy materials for the Annual Meeting previously distributed, you are entitled to participate in the Annual Meeting
if you were a shareholder as of the close of business on February 11, 2020, the record date, or hold a legal proxy for the meeting
provided by your bank, broker, or nominee. To be admitted to the Annual Meeting at </FONT><FONT STYLE="color: #1155CC; background-color: white">http://viewproxy.com/Anavex/2020/vm/</FONT><FONT STYLE="line-height: 115%">,
you are requested to pre-register at </FONT>http://www.viewproxy.com/anavex/2020/ <FONT STYLE="line-height: 115%">by April 5, 2020.
In order to pre-register, you will be required to enter the control number found on your proxy card, voting instruction form or
notice you previously received and beneficial holders will be required to obtain a legal proxy. You may vote during the Annual
Meeting by following the instructions available on the meeting website during the meeting. </FONT></P>



<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="line-height: 115%">Whether
or not you plan to attend the Annual Meeting, we urge you to vote and submit your proxy in advance of the meeting by one of the
methods described in the proxy materials for the Annual Meeting. The proxy card included with the proxy materials previously distributed
will not be updated to reflect the change in location and may continue to be used to vote your shares in connection with the Annual
Meeting. The <B>Annual Meeting on April 7, 2020 at 10:00 a.m. Eastern Time will be available at </B></FONT><B><FONT STYLE="color: #1155CC; background-color: white">http://viewproxy.com/Anavex/2020/vm/</FONT><FONT STYLE="line-height: 115%">.</FONT></B><FONT STYLE="line-height: 115%">
The Proxy Statement and 2019 Annual Report are available at http://www.viewproxy.com/Anavex/2020. </FONT></P>



<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>



<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We look forward to
your continued support.</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 0 4.25in">Sincerely,</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 0 4.25in"><U>/s/ <I>Christopher Missling, PhD.</I></U></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 0 4.25in">Christopher Missling, PhD.<BR>
<I>Chief Executive Officer and </I></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 0 4.25in"><I>Chairman of the Board of Directors</I></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">March 23, 2020</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
